Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on business in Hong Kong as 國控股份有限公司)

(Stock Code: 01099) List of Directors and Their Role and Function

The members of the board of directors (the "Board") of Sinopharm Group Co. Ltd. are set out below:

Executive Director

Li Zhiming (Chairman)

Non-Executive Directors

Chen Qiyu She Lulin Wang Qunbin Ma Ping Deng Jindong Li Dongjiu

Lian Wanyong Wen Deyong

Independent Non-Executive Directors

Li Ling

Yu Tze Shan Hailson Tan Wee Seng

Liu Zhengdong Zhuo Fumin

There are 4 Board committees. The table below provides membership information of these committees on which each Board member serves.

Board Committee

Director

Audit Committee

Remuneration Committee

Nomination Committee

Strategy and Investment Committee

Li Zhiming

C

C

Chen Qiyu

M

She Lulin

M

M

Wang Qunbin

M

M

Ma Ping

M

Deng Jindong

M

Li Dongjiu

M

M

M

Lian Wanyong

M

Wen Deyong

Li Ling

M

M

Yu Tze Shan Hailson

M

M

Tan Wee Seng

C

M

Liu Zhengdong

M

C

M

Zhuo Fumin

M

M

Notes:

C Chairman of the relevant Board committees M Member of the relevant Board committees

Shanghai, the People's Republic of China 20 September 2017

Sinopharm Group Co. Ltd. published this content on 20 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 September 2017 14:04:04 UTC.

Original documenthttp://sinopharm.todayir.com/attachment/2017092016470200002925373_en.pdf

Public permalinkhttp://www.publicnow.com/view/D414EB345BCDDAA994033FAD994BE9A571D6AAC3